The Modernization of Cosmetic Regulations Act of 2022 does not create a framework for systematic cosmetic ingredient review at the US Food and Drug Administration, as other cosmetics reform proposals would have, but does include new requirements for substantiating the safety of cosmetic products.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?